We design and execute clinical studies, and innovate development programs in a broad variety of ophthalmic indications.
Beside our extensive experience in the area of corneal/limbal stem cell deficiency with tissue engineered products (ATMP trials), FGK has considerable knowledge in all areas of common ophthalmic diseases:
If you’re interested in our broad experience across managing the complexity of modern ophthalmology trial design, get in touch with us.